In CD8+ cells isolated from peripheral blood of tumor patients, the TLR2 agonist Pam3Csk4 enhanced the cytolytic activation of peripheral and tumor-infiltrating CD8+ T cells from GCs (18). The gene discussed is CD8A; the disease is neoplasm.